Chronic Lower Airway Disease

Asthma

A heterogeneous chronic respiratory disease characterized by variable symptoms and variable expiratory airflow limitation.

Variable airflow obstructionAirway inflammationOften reversible

Clinical vignette

A child with recurrent cough and wheezing

An 8-year-old presents with cough, chest tightness, and wheezing after several days of rhinorrhea. He has nighttime cough twice weekly and develops similar symptoms with exercise. Examination reveals tachypnea, subcostal retractions, diffuse expiratory wheezing, and prolonged expiration.

Your first clinical task

Assess the severity of the current exacerbation while also recognizing the pattern of chronic asthma symptoms.

Anatomy localization

Asthma is a disease of the conducting airways

Asthma primarily affects the medium and small bronchi through inflammation, bronchial smooth muscle constriction, and mucus production resulting in variable airflow obstruction.

Structures involved

  • • Medium and small bronchi
  • • Bronchial smooth muscle
  • • Airway mucosa
  • • Goblet cells and mucus glands

Structures usually spared

  • • Alveoli
  • • Pleural space
  • • Pulmonary vasculature
  • • Lung parenchyma

Clinical implication

Because asthma affects the conducting airways rather than the alveoli, patients typically present with wheezing, prolonged expiration, chest tightness, and airflow obstruction rather than focal crackles or consolidation.

Pathophysiology

Inflammation plus reversible airway narrowing

Asthma anatomy localization and comparison of a normal airway with an asthmatic airway showing bronchoconstriction, inflammation, mucus production, and airway remodeling

Airway inflammation

Chronic inflammation makes the airways hyperresponsive to triggers.

Bronchoconstriction

Airway smooth muscle contracts, producing variable airflow obstruction.

Mucus production

Increased secretions further narrow the airway lumen.

Air trapping

Expiration becomes prolonged and incomplete, causing hyperinflation.

History and physical exam

Confirm the pattern and identify risk

History

  • • Episodic wheeze, cough, dyspnea, or chest tightness
  • • Nighttime or early-morning symptoms
  • • Exercise, viral, allergen, smoke, or weather triggers
  • • Prior emergency visits, hospitalization, or intubation
  • • Controller adherence and inhaler technique
  • • Atopy, eczema, allergic rhinitis, and family history

Physical exam

  • • Respiratory rate and oxygen saturation
  • • Retractions and accessory muscle use
  • • Ability to speak, feed, or ambulate
  • • Wheezing and prolonged expiration
  • • Air entry, including a concerning silent chest
  • • Mental status and signs of fatigue

Acute severity

How sick is the child right now?

Mild

Speaks normally, mild wheeze or retractions, good air movement.

Moderate

Increased work of breathing, more persistent wheeze, reduced activity or speech.

Severe

Marked retractions, difficulty speaking, poor air entry, agitation, or hypoxemia.

Impending respiratory failure

Fatigue, altered mental status, cyanosis, silent chest, or worsening despite treatment.

Future feature: an interactive severity tool using work of breathing, speech, oxygenation, air entry, and mental status.

Differential diagnosis

Not every wheezing child has asthma

Bronchiolitis

Usually a first episode in an infant with viral symptoms, crackles, and diffuse wheezing.

Foreign body aspiration

Abrupt onset, choking history, asymmetric air entry, or focal wheeze.

Pneumonia

Fever, focal crackles, focal decreased air entry, or toxic appearance.

Anaphylaxis

Acute respiratory symptoms with urticaria, angioedema, hypotension, or gastrointestinal symptoms.

Vocal cord dysfunction

Inspiratory symptoms, throat tightness, stridor, or poor response to asthma therapy.

Diagnostic workup

Confirm variable airflow obstruction and avoid unnecessary testing

Asthma is diagnosed by a characteristic pattern of variable respiratory symptoms together with objective evidence of variable expiratory airflow limitation when testing is feasible.

Initial evaluation

  • • Detailed symptom and trigger history
  • • Prior exacerbations and response to treatment
  • • Physical examination and oxygen saturation
  • • Assessment of atopy and relevant comorbidities
  • • Review of inhaler technique and medication adherence

Objective lung-function testing

  • • Perform spirometry with bronchodilator testing when the child is developmentally able
  • • Look for reduced expiratory airflow before treatment
  • • Repeat testing after an inhaled bronchodilator
  • • Improvement in airflow supports variable, reversible obstruction
  • • Normal spirometry between episodes does not completely exclude asthma

When the diagnosis remains uncertain

Additional options

  • • Repeat spirometry during symptoms
  • • Serial peak expiratory flow measurements
  • • Exercise or bronchoprovocation testing
  • • Specialist-directed allergy evaluation

Fractional exhaled nitric oxide

FeNO may support the diagnosis of type 2 airway inflammation when asthma remains uncertain, but it should be interpreted as an adjunct rather than used alone to diagnose or exclude asthma.

Avoid routinely in a typical exacerbation

  • • Chest radiograph
  • • CBC or inflammatory markers
  • • Respiratory viral testing
  • • Blood cultures
  • • Arterial or venous blood gas
  • • CT imaging

Consider targeted testing when

  • • Findings are focal or markedly asymmetric
  • • Foreign body aspiration is possible
  • • Pneumonia or pneumothorax is suspected
  • • The diagnosis is uncertain or the course is atypical
  • • The child fails to improve as expected
  • • Respiratory failure or another complication is suspected

Severe-asthma warning

A normal or rising carbon dioxide level may be ominous

Early in an asthma exacerbation, children commonly hyperventilate and lower their carbon dioxide level. In a child with severe distress, a normalizing or rising carbon dioxide level may indicate worsening fatigue and inadequate ventilation.

Decreasing wheeze with worsening air movement may represent a silent chest—not clinical improvement.

Management overview

Treat bronchoconstriction and inflammation

Short-acting bronchodilator

Administer inhaled albuterol for acute bronchoconstriction.

Systemic corticosteroid

Use early for moderate or severe exacerbations or incomplete response to initial bronchodilator therapy.

Oxygen

Provide supplemental oxygen when hypoxemia is present.

Escalation

Consider repeated or continuous bronchodilator therapy, ipratropium, magnesium, and higher-level respiratory support according to severity and local pathway.

Chronic-care principle

Asthma management should include an inhaled corticosteroid-containing strategy, assessment of symptom control and future risk, inhaler technique, adherence, trigger reduction, and a written asthma action plan.

Disposition

Reassess the response—not just the initial appearance

Disposition depends on the child's clinical response after initial treatment, oxygen requirement, work of breathing, air movement, ability to speak or feed, prior high-risk history, and the safety of outpatient follow-up.

Consider discharge

  • • Symptoms and work of breathing are substantially improved
  • • Air movement is good without concerning fatigue
  • • Oxygenation is stable on room air
  • • Bronchodilator treatments can be spaced appropriately
  • • The child can speak, drink, and ambulate near baseline
  • • Caregivers understand treatment and return precautions
  • • Reliable follow-up and access to medications are available

Consider hospital admission

  • • Persistent moderate or severe respiratory distress
  • • Continued oxygen requirement or recurrent hypoxemia
  • • Need for frequent or continuous bronchodilator therapy
  • • Incomplete or short-lived response to initial treatment
  • • Poor oral intake, dehydration, or inability to manage at home
  • • High-risk history or significant comorbidity
  • • Unsafe social situation or unreliable follow-up

Escalate to intensive care

  • • Worsening despite aggressive initial therapy
  • • Markedly reduced air movement or silent chest
  • • Exhaustion, confusion, drowsiness, or agitation
  • • Persistent or worsening hypoxemia
  • • Rising carbon dioxide or evidence of ventilatory failure
  • • Need for advanced or rapidly escalating respiratory support
  • • Concern for impending respiratory arrest

Discharge bundle

Stabilization is only half of the job

Confirm an inhaled corticosteroid-containing treatment plan

Provide an appropriate reliever plan

Complete the prescribed systemic corticosteroid course when indicated

Demonstrate inhaler and spacer technique

Review triggers, adherence, and barriers to obtaining medication

Provide a written asthma action plan

Give clear return precautions

Arrange timely outpatient follow-up

High-risk history

Prior intensive-care admission, previous intubation, recent emergency visits or systemic corticosteroid courses, poor controller adherence, medication-access barriers, and psychosocial concerns should lower the threshold for observation, admission, or specialist involvement.

Exact admission, oxygen, and bronchodilator-spacing criteria vary by institution. Apply the local pediatric asthma pathway when making clinical decisions.

Clinical pearls

High-yield asthma takeaways

Wheezing intensity does not equal disease severity

A child with minimal wheezing but very poor air movement may be more critically ill than a child with loud wheezing and good air exchange.

A silent chest is an emergency

Diminishing wheeze accompanied by worsening work of breathing, fatigue, altered mental status, or poor air movement suggests critically limited airflow—not improvement.

Treat before ordering routine tests

A typical asthma exacerbation is assessed clinically, and urgent bronchodilator treatment should not be delayed for routine chest radiography or laboratory testing.

Look beyond the current exacerbation

Ask about nighttime symptoms, exercise limitation, prior emergency visits, systemic steroid courses, hospitalization, intensive-care admission, and previous intubation.

Inhaler technique is part of the treatment

Before escalating long-term therapy, confirm that the medication is being taken, the inhaler technique is correct, and the child has an appropriate spacer.

Asthma control and asthma severity are not the same

Control describes the child's current symptoms and future risk, while severity is judged retrospectively by the treatment required to maintain control.

Every child needs a plan after stabilization

Discharge planning should address controller therapy, reliever use, trigger reduction, spacer technique, follow-up, and a written asthma action plan.

Do not miss

Less wheezing can mean less airflow.

Always interpret wheezing together with air entry, respiratory effort, speech, oxygenation, fatigue, and mental status.

Knowledge check

What is the best next step?

A 9-year-old with known asthma presents with diffuse wheezing, moderate intercostal retractions, and difficulty speaking in full sentences. Oxygen saturation is 91% on room air. Which initial treatment is most appropriate?

Evidence Base

Clinical References

Global Initiative for Asthma

Global Strategy for Asthma Management and Prevention, 2026.

National Asthma Education and Prevention Program

2020 Focused Updates to the Asthma Management Guidelines.

Educational Disclaimer

PediAtlas is intended for medical education and should not replace institutional guidelines, local protocols, patient-specific assessment, or clinical judgment.

Feedback